Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 17, 2008, Pages 7781-7789

  Lee, Young A ^a   Eun, Ju Cho ^b   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Pusan National University   (South Korea)

Author keywords

db db mice; Hyperlipidemia; Oxidative stress; Proanthocyanidin; Type 2 diabetes

Indexed keywords

CHOLESTEROL; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROANTHOCYANIDIN; SREBF1 PROTEIN, MOUSE; SREBF2 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMISTRY; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIVER; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; HYPERLIPIDEMIAS; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; PPAR ALPHA; PROANTHOCYANIDINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIGLYCERIDES;

DIOSPYROS; MUS;

EID: 52649118111     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf800639m     Document Type: Article

References (42)

1. Shimabukuro, M.; Zhou, Y. T.; Levi, M.; Unger, R. H. Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 2498-2502.
2. McGarry, J. D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51, 7-18.
3. Poitout, V.; Robertson, R. P. Minireview: Secondary β-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002, 143, 339-342.
4. Prentki, M.; Joly, E.; El-Assaad, W.; Roduit, R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 2002, 51, S405-S413.
5. Gorinstein, S.; Zemser, M.; Weisz, M.; Halevy, S.; Deutsch, J.; Tilis, K.; Feintuch, D.; Guerra, N.; Fishman, M.; Bartnikowska, E. Fluorometric analysis of phenolics in persimmons. Biosci. Biotech. Biochem. 1994, 58, 1087-1092.
6. Gorinstein, S.; Zachwieja, Z.; Folta, M.; Barton, H.; Piotrowicz, J.; Zemser, M.; Weisz, M.; Trakhtenberg, S.; Màrtín-Belloso, O. Comparative contents of dietary fiber, total phenolics, and minerals in persimmons and apples. J. Agric. Food Chem. 2001, 49, 952-957.
7. Dixon, R. A.; Xie, D. Y.; Sharma, S. B. Proanthocyanidins-a final frontier in flavonoid research. New Phytol. 2005, 165, 9-28.
8. Xie, D. Y.; Dixon, R. A. Proanthocyanidin biosynthesis - still more questions than answers. Phytochemistry 2005, 66, 2127-2144.
9. Lee, Y. A; Cho, E. J.; Tanaka, T.; Yokozawa, T. Inhibitory activities of proanthocyanidins from persimmon against oxidative stress and digestive enzymes related to diabetes. J. Nutr. Sci. Vitaminol. 2007, 53, 287-292.
10. Lee, Y. A; Kim, Y. J.; Cho, E. J.; Yokozawa, T. Ameliorative effects of proanthocyanidin on oxidative stress and inflammation in streptozotocin-induced diabetic rats. J. Agric. Food Chem. 2007, 55, 9395-9400.
11. Hummel, K. P.; Dickie, M. M.; Coleman, D. L. Diabetes, a new mutation in the mouse. Science 1966, 153, 1127-1128.
12. Kaku, K.; Province, M.; Permutt, M. A. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control. Diabetologia 1989, 32, 636-643.
13. Münzberg, H.; Myers, M. G., Jr. Molecular and anatomical determinants of central leptin resistance. Nat. Neurosci. 2005, 8, 566-570.
14. Tanaka, T.; Takahashi, R.; Kouno, I.; Nonaka, G. I. Chemical evidence for the de-astringency (insolubilization of tannins) of persimmon fruit. J. Chem. Soc., Perkin Trans. 1 1994, 3013-3022.
15. Fluckiger, R.; Winterhalter, K. H. In vitro synthesis of hemoglobin AIc. FEBS Lett. 1976, 71, 356-360.
16. Folch, J.; Lees, M.; Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
17. Ali, S. F.; LeBel, C. P.; Bondy, S. C. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 1992, 13, 637-648.
18. Mihara, M.; Uchiyama, M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86, 271-278.
19. Hissin, P. J.; Hilf, R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74, 214-226.
20. Itzhaki, R. F.; Gill, D. M. A micro-biuret method for estimating proteins. Anal. Biochem. 1964, 9, 401-410.
21. Komatsu, S. Extraction of nuclear proteins. Methods Mol. Biol. 2007, 355, 73-77.
22. Scott, J. A.; King, G. L. Oxidative stress and antioxidant treatment in diabetes. Ann. N. Y. Acad. Sci. 2004, 1031, 204-213.
23. Tushuizen, M. E.; Bunck, M. C.; Pouwels, P. J.; Bontemps, S.; van Waesberghe, J. H.; Schindhelm, R. K.; Mari, A.; Heine, R. J.; Diamant, M. Pancreatic fat content and β-cell function in men with and without type 2 diabetes. Diabetes Care 2007, 30, 2916-2921.
24. Muoio, D. M.; Lynis Dohm, G. Peripheral metabolic actions of leptin. Best Pract. Res., Clin. Endocrinol. Metab. 2002, 16, 653-666.
25. Sharma, K.; McCue, P.; Dunn, S. R. Diabetic kidney disease in the db/db mouse. Am. J. Physiol. Renal Physiol. 2003, 284, F1138-F1144.
26. Horigome, T.; Kumar, R.; Okamoto, K. Effects of condensed tannins prepared from leaves of fodder plants on digestive enzymes in vitro and in the intestine of rats. Br. J. Nutr. 1988, 60, 275-285.
27. Shishikura, Y.; Khokhar, S.; Murray, B. S. Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J. Agric. Food Chem. 2006, 54, 1906-1913.
28. Evans, J. L.; Goldfine, I. D.; Maddux, B. A.; Grodsky, G. M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction. Diabetes 2003, 52, 1-8.
29. Niki, E.; Yamamoto, Y.; Komuro, E.; Sato, K. Membrane damage due to lipid oxidation. Am. J. Clin. Nutr. 1991, 53, 201S-205S.
30. Bravi, M. C.; Armiento, A.; Laurenti, O.; Cassone-Faldetta, M.; De Luca, O.; Moretti, A.; De Mattia, G. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism 2006, 55, 691-695.
31. de Boer, V.C. J.; de Goffau, M. C.; Arts, I. C. W.; Hollman, P. C. H.; Keijer, J. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech. Ageing Dev. 2006, 127, 618-627.
32. Wu, C. H.; Yen, G. C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J. Agric. Food Chem. 2005, 53, 3167-3173.
33. Yahagi, N.; Shimano, H.; Hasty, A. H.; Matsuzaka, T.; Ide, T.; Yoshikawa, T.; Amemiya-Kudo, M.; Tomita, S.; Okazaki, H.; Tamura, Y.; Iizuka, Y.; Ohashi, K.; Osuga, J.; Harada, K.; Gotoda, T.; Nagai, R.; Ishibashi, S.; Yamada, N. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J. Biol. Chem. 2002, 277, 19353-19357.
34. Shimano, H.; Yahagi, N.; Amemiya-Kudo, M.; Hasty, A. H.; Osuga, J.; Tamura, Y.; Shionoiri, F.; Iizuka, Y.; Ohashi, K.; Harada, K.; Gotoda, T.; Ishibashi, S.; Yamada, N. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 1999, 274, 35832-35839.
35. Tobe, K.; Suzuki, R.; Aoyama, M.; Yamauchi, T.; Kamon, J.; Kubota, N.; Terauchi, Y.; Matsui, J.; Akanuma, Y.; Kimura, S.; Tanaka, J.; Abe, M.; Ohsumi, J.; Nagai, R.; Kadowaki, T. Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver. J. Biol. Chem. 2001, 276, 38337-38340.
36. Wang, Z.; Jiang, T.; Li, J.; Proctor, G.; McManaman, J. L.; Lucia, S.; Chua, S.; Levi, M. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 2005, 54, 2328-2335.
37. Ferré, P. The biology of peroxisome proliferator-activated recep-tors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53, S43-S50.
38. Evans, J. L.; Goldfine, I. D.; Maddux, B. A.; Grodsky, G. M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23, 599-622.
39. Celec, P. Nuclear factor κB-molecular biomedicine: the next generation. Biomed. Pharmacother. 2004, 58, 365-371.
40. Surh, Y. J.; Chun, K. S.; Cha, H. H.; Han, S. S.; Keum, Y. S.; Park, K. K.; Lee, S. S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 2001, 480-481, 243-268.
41. Sinha, S.; Perdomo, G.; Brown, N. F.; O'Doherty, R. M. Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor κB. J. Biol. Chem. 2004, 279, 41294-41301.
42. Fujimoto, M.; Shimizu, N.; Kunii, K.; Martyn, J. A.; Ueki, K.; Kaneki, M. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 2005, 54, 1340-1348.